Brella received FDA clearance last week for improving excessive underarm sweating.
Doris Day, MD, FAAD
Advertisement
Articles by Doris Day, MD, FAAD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Kyowa Kirin Takes Full Control of Rocatinlimab Program
2
Dermatology Times January 2026 Recap
3
Phase 2 TYK2 Inhibition Shows Promise in AD
4
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
5